(Q35065472)

6 August 2017

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade (English)

1 reference

6 August 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

Mercedes Iñarrairaegui

Mercedes Iñarrairaegui

14

0 references

Rebecca Miksad

Rebecca Miksad

17

0 references

James O'Beirne

James O'Beirne

7

0 references

Stephen L Chan

Stephen L Chan

15

0 references

Bruno Sangro

Bruno Sangro

16

0 references

Winnie Yeo

Winnie Yeo

11

0 references

Takashi Kumada

19

Takashi Kumada

1 reference

6 August 2017

20

Hidenori Toyoda

1 reference

6 August 2017

18

Toshifumi Tada

1 reference

6 August 2017

3

Chiaki Kagebayashi

1 reference

6 August 2017

4

Shinji Satomura

1 reference

6 August 2017

2

Sarah Berhane

1 reference

6 August 2017

6

Helen L Reeves

1 reference

6 August 2017

13

Paul Lai

1 reference

6 August 2017

Philip J Johnson

1

1 reference

6 August 2017

Mabel Teng

5

1 reference

6 August 2017

Richard Fox

8

1 reference

6 August 2017

Anna Skowronska

9

1 reference

6 August 2017

Daniel Palmer

10

1 reference

6 August 2017

Frankie Mo

12

1 reference

6 August 2017

language of work or name

English

0 references

publication date

15 December 2014

1 reference

Journal of Clinical Oncology

6 August 2017

1 reference

6 August 2017

33

1 reference

6 August 2017

6

1 reference

6 August 2017

550-558

1 reference

Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model.

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Management of hepatocellular carcinoma: An update

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Assessment of prognosis of cirrhosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Management of hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Prognosis of hepatocellular carcinoma: the BCLC staging classification

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Treatment of continuous data as categoric variables in Obstetrics and Gynecology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Surgery and portal hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Transection of the oesophagus for bleeding oesophageal varices

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Cirrhosis and the aetiology of hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Hepatocellular carcinoma. A worldwide problem and the major risk factors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322258

Dichotomizing continuous predictors in multiple regression: a bad idea

16 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25512453

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2014.57.9151

1 reference

release_zpscbllvobaspnhh27mx6mc6r4

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zpscbllvobaspnhh27mx6mc6r4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

4322258

1 reference

6 August 2017

1 reference